Related references
Note: Only part of the references are listed.Oncogenic miR-544 is an Important Molecular Target in Gastric Cancer
Qiaoming Zhi et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2013)
Gastric Juice MicroRNAs as Potential Biomarkers for the Screening of Gastric Cancer
Long Cui et al.
CANCER (2013)
Oncogenic ERBB3 Mutations in Human Cancers
Bijay S. Jaiswal et al.
CANCER CELL (2013)
MicroRNA Expression Signatures during Malignant Progression from Barrett's Esophagus to Esophageal Adenocarcinoma
Xifeng Wu et al.
CANCER PREVENTION RESEARCH (2013)
miR-17-5p/20a are important markers for gastric cancer and murine double minute 2 participates in their functional regulation
Mei Wang et al.
EUROPEAN JOURNAL OF CANCER (2013)
MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer
Hongxia Deng et al.
GENE (2013)
Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer
Tatiana Ivanova et al.
GUT (2013)
Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancer
Yonghui Wu et al.
GUT (2013)
Helicobacter pylori Induces Increased Expression of Toll-Like Receptors and Decreased Toll-Interacting Protein in Gastric Mucosa that Persists Throughout Gastric Carcinogenesis
Pedro Pimentel-Nunes et al.
HELICOBACTER (2013)
Clinicopathologic significance of miR-10b expression in gastric carcinoma
Yuan-Yu Wang et al.
HUMAN PATHOLOGY (2013)
The tumor suppressor microRNA-29c is downregulated and restored by celecoxib in human gastric cancer cells
Yoshimasa Saito et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Risk of advanced gastric precancerous lesions in Helicobacter pylori infected subjects is influenced by ABO blood group and cagA status
Cosmeri Rizzato et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Recapitulation of previous genome-wide association studies with two distinct pathophysiological entities of gastric cancer in the Korean population
Joo-Yeon Hwang et al.
JOURNAL OF HUMAN GENETICS (2013)
miRNA-145 Targets v-ets Erythroblastosis Virus E26 Oncogene Homolog 1 to Suppress the Invasion, Metastasis, and Angiogenesis of Gastric Cancer Cells
Liduan Zheng et al.
MOLECULAR CANCER RESEARCH (2013)
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
Tom Waddell et al.
LANCET ONCOLOGY (2013)
Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial
Florian Lordick et al.
LANCET ONCOLOGY (2013)
The role of microRNAs in cancers of the upper gastrointestinal tract
Shumei Song et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancer
Hui Cai et al.
MEDICAL ONCOLOGY (2013)
Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells
Weiguo Cao et al.
TUMOR BIOLOGY (2013)
miR-133b acts as a tumor suppressor and negatively regulates FGFR1 in gastric cancer
Dacheng Wen et al.
TUMOR BIOLOGY (2013)
Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases
S. Akiyoshi et al.
BRITISH JOURNAL OF CANCER (2012)
Prostate Stem Cell Antigen Polymorphisms and Susceptibility to Gastric Cancer: A Systematic Review and Meta-analysis
Tao Wang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Reactive Oxygen Species-Induced Autophagic Degradation of Helicobacter pylori CagA Is Specifically Suppressed in Cancer Stem-like Cells
Hitoshi Tsugawa et al.
CELL HOST & MICROBE (2012)
Impact of Expression of Human Epidermal Growth Factor Receptors EGFR and ERBB2 on Survival in Stage II/III Gastric Cancer
Masanori Terashima et al.
CLINICAL CANCER RESEARCH (2012)
Genetic variation in C20orf54, PLCE1 and MUC1 and the risk of upper gastrointestinal cancers in Caucasian populations
Andrew J. Palmer et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2012)
Downregulation of miR-101 in gastric cancer correlates with cyclooxygenase-2 overexpression and tumor growth
Xiao-Pu He et al.
FEBS JOURNAL (2012)
Circulating MicroRNA in Digestive Tract Cancers
Daisuke Ichikawa et al.
GASTROENTEROLOGY (2012)
A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets
Niantao Deng et al.
GUT (2012)
Relevance of MET activation and genetic alterations of KRAS and E-cadherin for cetuximab sensitivity of gastric cancer cell lines
Stefan Heindl et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Multistep activation of the Helicobacter pylori effector CagA
Anne Mueller
JOURNAL OF CLINICAL INVESTIGATION (2012)
c-Src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in Western and East Asian Helicobacter pylori strains
Doreen Mueller et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Adjuvant Capecitabine, Docetaxel, Cyclophosphamide, and Epirubicin for Early Breast Cancer: Final Analysis of the Randomized FinXX Trial
Heikki Joensuu et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Salvage Chemotherapy for Pretreated Gastric Cancer: A Randomized Phase III Trial Comparing Chemotherapy Plus Best Supportive Care With Best Supportive Care Alone
Jung Hun Kang et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Cervical Adenocarcinoma in a Patient With Lynch Syndrome, Muir-Torre Variant
Navya Nair et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Phase I Trial and Pharmacokinetic Study of Lexatumumab in Pediatric Patients With Solid Tumors
Melinda S. Merchant et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Biomarker Evaluation From the AVAGAST Randomized Phase III Trial
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial
Jeeyun Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Updated Analysis of SWOG-Directed Intergroup Study 0116: A Phase III Trial of Adjuvant Radiochemotherapy Versus Observation After Curative Gastric Cancer Resection
Stephen R. Smalley et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer
Manuel Valladares-Ayerbes et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Replication study of PLCE1 and C20orf54 polymorphism and risk of esophageal cancer in a Chinese population
Haiyong Gu et al.
MOLECULAR BIOLOGY REPORTS (2012)
microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-κB by targeting CARD10 and COPS8 in gastric cancer
Stephanie Geisler Crone et al.
MOLECULAR CANCER (2012)
MET Activation Mediates Resistance to Lapatinib Inhibition of HER2-Amplified Gastric Cancer Cells
Chin-Tung Chen et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2012)
Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+Breast Cancer by Expanding the Cancer Stem Cell Population
Hasan Korkaya et al.
MOLECULAR CELL (2012)
Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes
Zhi Jiang Zang et al.
NATURE GENETICS (2012)
Targeted Therapy in the Management of Advanced Gastric Cancer: Are We Making Progress in the Era of Personalized Medicine?
Hilda Wong et al.
ONCOLOGIST (2012)
Potentially Functional Variants of PLCE1 Identified by GWASs Contribute to Gastric Adenocarcinoma Susceptibility in an Eastern Chinese Population
Mengyun Wang et al.
PLOS ONE (2012)
Involvement of Aquaporin 3 in Helicobacter pylori-Related Gastric Diseases
Gang Wang et al.
PLOS ONE (2012)
Three-gene predictor of clinical outcome for gastric cancer patients treated with chemotherapy
H. K. Kim et al.
PHARMACOGENOMICS JOURNAL (2012)
Improving Treatment of HER2-Positive Cancers: Opportunities and Challenges
Howard M. Stern
SCIENCE TRANSLATIONAL MEDICINE (2012)
Methylation Subtypes and Large-Scale Epigenetic Alterations in Gastric Cancer
Hermioni Zouridis et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Gastric juice microRNA-421 is a new biomarker for screening gastric cancer
Xinjun Zhang et al.
TUMOR BIOLOGY (2012)
Decreased expression of microRNA let-7i and its association with chemotherapeutic response in human gastric cancer
Kun Liu et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2012)
Comparisons of Gastric Cancer Treatments: East vs. West
Kai Bickenbach et al.
JOURNAL OF GASTRIC CANCER (2012)
The ubiquitin-proteasome system and signal transduction pathways regulating Epithelial Mesenchymal transition of cancer
Ioannis A. Voutsadakis
JOURNAL OF BIOMEDICAL SCIENCE (2012)
Inhibition of IGF1R activity enhances response to trastuzumab in HER-2-positive breast cancer cells
B. C. Browne et al.
ANNALS OF ONCOLOGY (2011)
Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS)
Johan L. Dikken et al.
BMC CANCER (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Insulin-Like Growth Factor-I Receptor Blockade Reduces Tumor Angiogenesis and Enhances the Effects of Bevacizumab for a Human Gastric Cancer Cell Line, MKN45
Hua Li et al.
CANCER (2011)
CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc- and Thereby Promotes Tumor Growth
Takatsugu Ishimoto et al.
CANCER CELL (2011)
MET Expression and Amplification in Patients with Localized Gastric Cancer
Yelena Y. Janjigian et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphoma
Sung Soo Kim et al.
CANCER LETTERS (2011)
Genetic variants at 1q22 and 10q23 reproducibly associated with gastric cancer susceptibility in a Chinese population
Hanze Zhang et al.
CARCINOGENESIS (2011)
Gene Expression Signature-Based Prognostic Risk Score in Gastric Cancer
Jae Yong Cho et al.
CLINICAL CANCER RESEARCH (2011)
Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer - A randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
Peter C. Thuss-Patience et al.
EUROPEAN JOURNAL OF CANCER (2011)
Intrinsic Subtypes of Gastric Cancer, Based on Gene Expression Pattern, Predict Survival and Respond Differently to Chemotherapy
Iain Beehuat Tan et al.
GASTROENTEROLOGY (2011)
A Functional Single Nucleotide Polymorphism in Mucin 1, at Chromosome 1q22, Determines Susceptibility to Diffuse-Type Gastric Cancer
Norihisa Saeki et al.
GASTROENTEROLOGY (2011)
Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer
Mitsuru Sasako et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
MET Amplification Identifies a Small and Aggressive Subgroup of Esophagogastric Adenocarcinoma With Evidence of Responsiveness to Crizotinib
Jochen K. Lennerz et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
Atsushi Ohtsu et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
Marc Ychou et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Genetic variation in PLCE1 is associated with gastric cancer survival in a Chinese population
Dewei Luo et al.
JOURNAL OF GASTROENTEROLOGY (2011)
A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1
Yongyong Shi et al.
NATURE GENETICS (2011)
Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer
Kai Wang et al.
NATURE GENETICS (2011)
Anti-HER agents in gastric cancer: from bench to bedside
Lorenzo Fornaro et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
A Gene Expression Signature of Acquired Chemoresistance to Cisplatin and Fluorouracil Combination Chemotherapy in Gastric Cancer Patients
Hark Kyun Kim et al.
PLOS ONE (2011)
Epidermal growth factor receptor mutation in gastric cancer
Zhimin Liu et al.
PATHOLOGY (2011)
Hedgehog Signaling Antagonist GDC-0449 (Vismodegib) Inhibits Pancreatic Cancer Stem Cell Characteristics: Molecular Mechanisms
Brahma N. Singh et al.
PLOS ONE (2011)
Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinase
Joan T. Garrett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype
Yunqing Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Gene Expression Profile Prospectively Predicts Peritoneal Relapse After Curative Surgery of Gastric Cancer
Atsushi Takeno et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Bone marrow-derived mesenchymal stem cells and the tumor microenvironment
Scott A. Bergfeld et al.
CANCER AND METASTASIS REVIEWS (2010)
Genetic profiles of gastroesophageal cancer: combined analysis using expression array and tiling array-comparative genomic hybridization
Anna Isinger-Ekstrand et al.
CANCER GENETICS AND CYTOGENETICS (2010)
MET and KRAS Gene Amplification Mediates Acquired Resistance to MET Tyrosine Kinase Inhibitors
Virna Cepero et al.
CANCER RESEARCH (2010)
Prostate Stem Cell Antigen: A Jekyll and Hyde Molecule?
Norihisa Saeki et al.
CLINICAL CANCER RESEARCH (2010)
Anti-cancer drug resistance: Understanding the mechanisms through the use of integrative genomics and functional RNA interference
Daniel S. -W. Tan et al.
EUROPEAN JOURNAL OF CANCER (2010)
Helicobacter pylori Infection Promotes Methylation and Silencing of Trefoil Factor 2, Leading to Gastric Tumor Development in Mice and Humans
Anthony J. Peterson et al.
GASTROENTEROLOGY (2010)
Promoter DNA hypermethylation in gastric biopsies from subjects at high and low risk for gastric cancer
Barbara G. Schneider et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Gastric Cancer-An Enigmatic and Heterogeneous Disease
Manish A. Shah et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer A Meta-analysis
Xavier Paoletti et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Multicenter Phase III Comparison of Cisplatin/S-1 With Cisplatin/Infusional Fluorouracil in Advanced Gastric or Gastroesophageal Adenocarcinoma Study: The FLAGS Trial
Jaffer A. Ajani et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Cancer Stem Cells: A Novel Paradigm for Cancer Prevention and Treatment
D. Subramaniam et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2010)
Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition
Simona Corso et al.
MOLECULAR CANCER (2010)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma
Christian C. Abnet et al.
NATURE GENETICS (2010)
Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54
Li-Dong Wang et al.
NATURE GENETICS (2010)
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
A. Singh et al.
ONCOGENE (2010)
Clinicopathological significance of E-cadherin, VEGF, and MMPs in gastric cancer
Yongning Zhou et al.
TUMOR BIOLOGY (2010)
Targeting the PI3K/Akt/mTOR Pathway - Beyond Rapalogs
Ben Markman et al.
ONCOTARGET (2010)
PTEN and the PI3-Kinase Pathway in Cancer
Nader Chalhoub et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
Helicobacter pylori causes runx3 gene methylation and its loss of expression in gastric epithelial cells, which is mediated by nitric oxide produced by macrophages
Yasumi Katayama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Phase II study of cetuximab in combination with cisplatin and docetaxel in patients with untreated advanced gastric or gastro-oesophageal junction adenocarcinoma (DOCETUX study)
C. Pinto et al.
BRITISH JOURNAL OF CANCER (2009)
Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
Heather A. Hirsch et al.
CANCER RESEARCH (2009)
Roles of TGF-beta family signaling in stem cell renewal and differentiation
Tetsuro Watabe et al.
CELL RESEARCH (2009)
Overexpression of Phosphorylated Mammalian Target of Rapamycin Predicts Lymph Node Metastasis and Prognosis of Chinese Patients with Gastric Cancer
Guanzhen Yu et al.
CLINICAL CANCER RESEARCH (2009)
Ectodomain shedding of E-cadherin and c-Met is induced by Helicobacter pylori infection
Wiebke Schirrmeister et al.
EXPERIMENTAL CELL RESEARCH (2009)
Recent patterns in gastric cancer: A global overview
Paola Bertuccio et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Molecular basis of therapeutic approaches to gastric cancer
Kaichun Wu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Diffuse-Type Gastric Carcinoma: Progression, Angiogenesis, and Transforming Growth Factor β Signaling
Akiyoshi Komuro et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Identification of novel Cyclooxygenase-2-dependent genes in Helicobacter pylori infection in vivo
Anna K. Walduck et al.
MOLECULAR CANCER (2009)
Effect of Helicobacter pylori infection on IL-8, IL-1 and COX-2 expression in patients with chronic gastritis and gastric cancer
Waldemar Bartchewsky et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44
Shigeo Takaishi et al.
STEM CELLS (2009)
Comparative Study on Overexpression of HER2/neu and HER3 in Gastric Cancer
Xiu Li Zhang et al.
WORLD JOURNAL OF SURGERY (2009)
Oncogenic Pathway Combinations Predict Clinical Prognosis in Gastric Cancer
Chia Huey Ooi et al.
PLOS GENETICS (2009)
Epidermal growth factor receptor structural alterations in gastric cancer
Catia Moutinho et al.
BMC CANCER (2008)
The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines
Jin Won Kim et al.
CANCER LETTERS (2008)
Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235
Pieter J. A. Eichhorn et al.
CANCER RESEARCH (2008)
Met receptor contributes to trastuzumab resistance of Her2-overexpressing breast cancer cells
David L. Shattuck et al.
CANCER RESEARCH (2008)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Molecular cancer therapy: Can our expectation be MET?
Cristina Migliore et al.
EUROPEAN JOURNAL OF CANCER (2008)
TNF-α-inducing protein, a carcinogenic factor secreted from H. pylori, enters gastric cancer cells
Masami Sujanuma et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Cancer stem cells and the ontogeny of lung cancer
Craig D. Peacock et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Gastric cancer stem cells
Shigeo Takaishi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
HER kinase activation confers resistance to MET tyrosine kinase inhibition in MET oncogene-addicted gastric cancer cells
Thomas Bachleitner-Hofmann et al.
MOLECULAR CANCER THERAPEUTICS (2008)
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
Wasaburo Koizumi et al.
LANCET ONCOLOGY (2008)
Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer
Hiromi Sakamoto et al.
NATURE GENETICS (2008)
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
Jeffrey A. Engelman et al.
NATURE MEDICINE (2008)
Linking epithelial polarity and carcinogenesis by multitasking Helicobacter pylori virulence factor CagA
M. Hatakeyama
ONCOGENE (2008)
Signaling networks assembled by oncogenic EGFR and c-Met
Ailan Guo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
PCR-SSCP-DNA sequencing method in detecting PTEN gene mutation and its significance in human gastric cancer
Chuan-Yong Guo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine
Shinichi Sakuramoto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance
Jiangbing Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Dramatic changes in the prevalence of Helicobacter pylori infection during childhood:: A 10-year follow-up study in Russia
Mikhail A. Tkachenko et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2007)
The phosphoinositide 3-kinase pathway in human cancer: Genetic alterations and therapeutic implications
Alexandre Arcaro et al.
CURRENT GENOMICS (2007)
Carcinogenesis of Helicobacter pylori
Pelayo Correa et al.
GASTROENTEROLOGY (2007)
Helicobacter pylori CagA interacts with E-cadherin and deregulates the β-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells
N. Murata-Kamiya et al.
ONCOGENE (2007)
Snail, ZEB and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
Hector Peinado et al.
NATURE REVIEWS CANCER (2007)
Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model
Sven A. Lang et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Decreasing seroprevalence of Helicobacter pylori infection during 1993-2003 in Guangzhou, Southern China
Jie Chen et al.
HELICOBACTER (2007)
Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium
Yuko Matsumoto et al.
NATURE MEDICINE (2007)
Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: A report of the V325 study group
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
TGFβ:: the molecular Jekyll and Hyde of cancer
Brian Bierie et al.
NATURE REVIEWS CANCER (2006)
Hedgehog signal activation in gastric pit cell and in diffuse-type gastric cancer
Masahide Fukaya et al.
GASTROENTEROLOGY (2006)
The global health burden of infection -associated cancers in the year 2002
Donald Maxwell Parkin
INTERNATIONAL JOURNAL OF CANCER (2006)
E-cadherin missense mutations, associated with hereditary diffuse gastric cancer (HDGC) syndrome, display distinct invasive behaviors and genetic interactions with the Wnt and Notch pathways in Drosophila epithelia
PS Pereira et al.
HUMAN MOLECULAR GENETICS (2006)
Gastric cancer screening and subsequent risk of gastric cancer: A large-scale population-based cohort study, with a 13-year follow-up in Japan
KJ Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752
GA Smolen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Interaction of CagA with Crk plays an important role in Helicobacter pylori-induced loss of gastric epithelial cell adhesion
M Suzuki et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Gene expression profile predicts patient survival of gastric cancer after surgical resection
CN Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
NF-κB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein
S Brandt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Cancer therapy: can the challenge be MET?
S Corso et al.
TRENDS IN MOLECULAR MEDICINE (2005)
Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection:: interactions influence outcome
CF Zambon et al.
CYTOKINE (2005)
Increased expression of matrix metalloproteinase-7 in invasive early gastric cancer
T Kitoh et al.
JOURNAL OF GASTROENTEROLOGY (2004)
Molecular mechanisms underlying IGF-I-induced attenuation of the growth-inhibitory activity of trastuzumab (Herceptin) on SKBR3 breast cancer cells
YH Lu et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Induction of cyclooxygenase-2 overexpression in human gastric epithelial cells by Helicobacter pylori involves TLR2/TLR9 and c-Src-dependent nuclear factor-κB activation
YJ Chang et al.
MOLECULAR PHARMACOLOGY (2004)
Common and distinct elements in cellular signaling via EGF and FGF receptors
J Schlessinger
SCIENCE (2004)
Growth inhibitory effects of trastuzumab and chemotherapeutic drugs in gastric cancer cell lines
SJ Gong et al.
CANCER LETTERS (2004)
Epidermal growth factor receptor expression correlates with histologic grade in resected esophageal adenocarcinoma
NW Wilkinson et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2004)
Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa
R Rad et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Frequent monoallelic deletion of PTEN and its reciprocal associatioin with PIk3CA amplification in gastric carcinoma
DS Byun et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Helicobacter pylori CagA -: a potential bacterial oncoprotein that functionally mimics the mammalian Gab family of adaptor proteins
M Hatakeyama
MICROBES AND INFECTION (2003)
Review article:: gastric cancer and Helicobacter pylori
A Axon
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Molecular biology of gastric cancer
W El-Rifai et al.
SEMINARS IN RADIATION ONCOLOGY (2002)
SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein
H Higashi et al.
SCIENCE (2002)
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.
JS Macdonald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations.
DG Huntsman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Helicobacter pylori activates mitogen-activated protein kinase cascades and induces expression of the proto-oncogenes c-fos and c-jun
T Meyer-ter-Vehn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
E-cadherin gene promoter hypermethylation in primary human gastric carcinomas
G Tamura et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Coexpression of interleukin-8 and inducible nitric oxide synthase in gastric mucosa infected with cagA(+) Helicobacter pylori
CQ Li et al.
DIGESTIVE DISEASES AND SCIENCES (2000)
Up-regulation and co-expression of fibroblast growth factor receptors in human gastric cancer
EY Shin et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2000)
Share Paper
